Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial

Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Ocular Therapeutix Inc]Follow[Regeneron Pharmaceuticals Inc]FollowFeb 17 (Reuters) - Ocular Therapeutix [(OCUL.O), opens new tab] said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron's [(REGN.O), opens new tab] appr ...